Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Two centuries of vaccination: historical and conceptual approach and future perspectives
David A. Montero, Roberto Vidal, Juliana Velasco, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 23
Comparative Effectiveness of Bivalent (Original/Omicron BA.4/BA.5) COVID-19 Vaccines in Adults
Hagit Kopel, Văn Hùng Nguyễn, Cathérine Boileau, et al.
Vaccines (2023) Vol. 11, Iss. 11, pp. 1711-1711
Open Access | Times Cited: 20
Key Considerations during the Transition from the Acute Phase of the COVID-19 Pandemic: A Narrative Review
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1502-1502
Open Access | Times Cited: 19
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez‐Baz, Noémie Sève, et al.
Eurosurveillance (2024) Vol. 29, Iss. 13
Open Access | Times Cited: 6
Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
Marzia Cavalli, Giulia Campoli, Anna Anselmo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Artificial intelligence for diagnosis of mild–moderate COVID-19 using haematological markers
Krishnaraj Chadaga, Srikanth Prabhu, Vivekananda Bhat K, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 14
Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis
Obaidur Rahman, Taro Kamigaki, Moe Moe Thandar, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e076892-e076892
Open Access | Times Cited: 13
Severity of Omicron Subvariants and Vaccine Impact in Catalonia, Spain
Víctor López de Rioja, Luca Basile, Aida Perramon, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 466-466
Open Access | Times Cited: 3
Key Essentials during the Transition from the Acute Phase of the COVID-19 Pandemic
Piotr Rzymski, Maria Pokorska‐Śpiewak, Teresa Jackowska, et al.
(2023)
Open Access | Times Cited: 9
Comparative Effectiveness of the Bivalent (Original/Omicron BA.4/BA.5) mRNA COVID-19 Vaccines mRNA-1273.222 and BNT162b2 Bivalent in Adults in the United States
Hagit Kopel, Văn Hùng Nguyễn, Cathérine Boileau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Three-year COVID-19 and flu vaccinations among medical residents in a tertiary hospital in Italy: The threat of acceptance decline in seasonal campaigns
Flavia Beccia, Alberto Lontano, Maria Francesca Rossi, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 6
Responses to Common Misconceptions Relating to COVID-19 Variant-Adapted mRNA Vaccines
George Kassianos, Pauline MacDonald, Ivan Dinesh Aloysius, et al.
Vaccines (2024) Vol. 12, Iss. 1, pp. 57-57
Open Access | Times Cited: 1
Factors associated with childhood non-vaccination against COVID-19 in Canada: A national survey analysis
David Guan, Sailly Dave, Marwa Ebrahim, et al.
Vaccine X (2024) Vol. 18, pp. 100478-100478
Open Access | Times Cited: 1
The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China
Yuxue Liao, Jiao Su, Jieru Zhao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Comprehensive statistical analysis reveals significant benefits of COVID-19 vaccination in hospitalized patients: propensity score, covariate adjustment, and feature importance by permutation
Esther Moraes, Magda Carvalho Pires, Amanda Abrantes Abreu Costa, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Effectiveness of bivalent mRNA booster vaccination and previous infection in older adults during Omicron period: real-world evidence
Pedro Pablo España, Idoia Castillo-Sintes, María José Legarreta, et al.
Age and Ageing (2024) Vol. 53, Iss. 11
Closed Access | Times Cited: 1
Health and Well-Being through COVID-19 Vaccination: Physical, Oral, and Psychological Effects
Kelvin I. Afrashtehfar, Carlos A. Jurado, Salem Abu-Fanas, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 4, pp. 3117-3117
Open Access | Times Cited: 3
Profile and Outcomes of Hospitalized COVID-19 Patients during the Prevalence of the Omicron Variant According to the Brazilian Regions: A Retrospective Cohort Study from 2022
Pedro Dutra Drummond, Daniel Bortot de Salles, Natália Satchiko Hojo de Souza, et al.
Vaccines (2023) Vol. 11, Iss. 10, pp. 1568-1568
Open Access | Times Cited: 3
The Antibodies’ Response to SARS-CoV-2 Vaccination: 1-Year Follow Up
Eleonora Nicolai, Flaminia Tomassetti, Martina Pelagalli, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2661-2661
Open Access | Times Cited: 2
Willingness to vaccinate among adults, and factors associated with vaccine acceptance of COVID-19 vaccines in a nationwide study in Poland between March 2021 and April 2022
Eftychia Kotronia, Magdalena Rosińska, Małgorzata Stępień, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
Effectiveness of Adapted COVID-19 Vaccines and Ability to Establish Herd Immunity against Omicron BA.1 and BA4-5 Variants of SARS-CoV-2
Pedro Plans-Rubió
Vaccines (2023) Vol. 11, Iss. 12, pp. 1836-1836
Open Access | Times Cited: 2
Stability Analysis of Covid-19 Model Based on Compliance and Carrier Transmission
Mukramati Mukramati, Afiatun Maghfirah, Marwan Ramli, et al.
ITM Web of Conferences (2024) Vol. 58, pp. 01003-01003
Open Access
Efficacy of adjuvant-associated COVID-19 vaccines against SARS-CoV-2 variants of concern in randomized controlled trials: A systematic review and meta-analysis
Meng-qun Cheng, Zhiying Weng, Rong Li, et al.
Medicine (2024) Vol. 103, Iss. 7, pp. e35201-e35201
Open Access
Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination
Christine Durier, Läétitia Ninove, Sylvie van der Werf, et al.
Infectious Diseases Now (2024) Vol. 54, Iss. 5, pp. 104886-104886
Open Access
Vaccine Effectiveness against GP-Attended Symptomatic COVID-19 and Hybrid Immunity among Adults in Hungary during the 2022–2023 Respiratory Season Dominated by Different SARS-CoV-2 Omicron Subvariants
J Horváth, Gergő Túri, Katalin Krisztalovics, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 496-496
Open Access
Page 1 - Next Page

Scroll to top